FDA approves Genentech’s Xolair for food allergies (OTCMKTS:RHHBY)
Bet_Noire The FDA has approved Roche's (OTCQX:RHHBY) asthma drug Xolair, which was developed by Roche unit Genentech, for the additional ...
Monday, November 25, 2024
Tag: Genentechs
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.